Innovative Drug Concept Gains Momentum; Kangchen Pharmaceutical Hits Two Straight Daily Limits
2025-07-11 / Read about 0 minute
Author:小编   

As of press time, stocks in the innovative drug sector have continued to gain momentum. Kangchen Pharmaceutical has achieved two consecutive daily trading limits. Changshan Pharmaceutical and Bioton Pharmaceutical each surged by over 10%, while WuXi AppTec posted gains of more than 7%. Additionally, Ascletis Pharma, Pharmaron, Jiuzhou Pharmaceutical, and Pulu Pharmaceutical also registered notable increases.